1 - 1 toradh á dtaispeáint as 1 toradh san iomlán ar an gcuardach '503 and RSV2004 Study Groups' Léim chuig an ábhar
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
CASTA
  • Údar
  • 503 and RSV2004 Study Groups
1 - 1 toradh á dtaispeáint as 1 toradh san iomlán ar an gcuardach '503 and RSV2004 Study Groups', am iarratais: 0.02s Beachtaigh na torthaí
  1. 1
    Lumicitabine, an orally administered nucleoside analog, in infants hospitalized with respiratory syncytial virus (RSV) infection: Safety, efficacy, and pharmacokinetic results.

    Lumicitabine, an orally administered nucleoside analog, in infants hospitalized with respiratory syncytial virus (RSV) infection: Safety, efficacy, and pharmacokinetic results. de réir Abbie Oey, Matthew McClure, Julian A Symons, Sushmita Chanda, John Fry, Patrick F Smith, Kathia Luciani, Michael Fayon, Kulkanya Chokephaibulkit, Rattapon Uppala, Jolanta Bernatoniene, Kenji Furuno, Thorsten Stanley, Dymphy Huntjens, James Witek, 503 and RSV2004 Study Groups

    Foilsithe / Cruthaithe 2023-01-01
    Faigh an téacs iomlán
    Alt

Uirlisí cuardaigh:

  • Faigh fotha RSS
  • Seol an cuardach seo mar r-phost

Roghanna cuardaigh

  • Stair cuardach
  • Cuardach Casta

Aimsigh tuilleadh

  • Brabhsáil an chatalóg
  • Brabhsáil in ord aibítre
  • Breathnaigh ar chainéil
  • Áirithintí cúrsa
  • Míreanna nua

Cabhair uait?

  • Leideanna cuardaigh
  • Cuir ceist ar leabharlannaí
  • CCanna